Lantheus Holdings Inc. (1LNTH)
MTA
Closed
Oct 2, 2026
Day's Range
87.7052 wk Range
43.37Overview - 1LNTH - Lantheus Holdings Inc.
Key Statistics
Valuation
Enterprise Value
5.03B
P/E (Trailing)
‪23.84‬
Price / Sales (TTM)
‪3.67‬
Price / Book
‪4.99‬
EV / EBITDA
‪14.64‬
Profitability
Gross Margin
‪62.30%‬
Profit Margin
‪17.69%‬
Operating Margin
‪25.81%‬
Return on Assets
‪8.37%‬
Return on Equity
‪22.21%‬
Ownership
Shares Outstanding
65.26M
Float
58.61M
Held by Insiders
‪1.73%‬
Held by Institutions
‪117.01%‬
Price stats
Beta
‪-0.03‬
50-Day Avg
‪87.84‬
200-Day Avg
‪75.23‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1LNTH - Lantheus Holdings Inc.
Peers - 1LNTH - Lantheus Holdings Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on MTA.
- 1LNTHMTALantheus Holdings Inc.3.88BMarket Cap+49.76%52-week change23.84P/E (Trailing)‪17.69%‬Profit Margin
- 1MRKMTAMerck KGaA55.65BMarket Cap+19.49%52-week change24.81P/E (Trailing)‪11.21%‬Profit Margin
- 1ZTSMTAZoetis Inc. Class A Common Stock48.46BMarket Cap-99.48%52-week change11.41P/E (Trailing)‪27.68%‬Profit Margin
- 1GALDMTAGalderma Group AG41.32BMarket Cap+15.70%52-week change53.11P/E (Trailing)‪14.57%‬Profit Margin
- 1NBIXMTANeurocrine Biosciences, Inc.12.55BMarket Cap+2.03%52-week change20.07P/E (Trailing)‪20.91%‬Profit Margin
- 1VTRSMTAViatris Inc.12.51BMarket Cap+46.86%52-week change-5.09P/E (Trailing)‪-2.78%‬Profit Margin
- 1SOBIMTASwedish Orphan Biovitrum AB10.24BMarket Cap+36.40%52-week change117.09P/E (Trailing)‪4.51%‬Profit Margin
Profile Summary - 1LNTH - Lantheus Holdings Inc.
About
Lantheus Holdings Inc. is a radiopharmaceutical-focused healthcare company that develops, manufactures, and commercializes diagnostic and therapeutic products used to help clinicians detect, localize, and monitor disease. Its portfolio centers on precision diagnostics and nuclear medicine solutions for oncology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
